Delay in seeking treatment is still the main barrier in receiving acute stroke therapy.
Chan
Lung
L
D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006297:Health Services Accessibility; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D013624:Taiwan; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator